Ozempic .68 mg/mL (Semaglutide INJECTION, SOLUTION) .68 mg/mL

Ozempic .68 mg/mL is a semaglutide injection used for managing type 2 diabetes. This subcutaneous solution helps control blood sugar levels. Learn more about Ozempic uses and effects.

Strength

.68 mg/mL

Pack Size

1 SYRINGE, PLASTIC in 1 CARTON (0169-4181-13) / 3 mL in 1 SYRINGE, PLASTIC (0169-4181-03)

Manufacturer / TM Owner

Novo Nordisk

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ozempic .68 mg/mL is primarily used for managing type 2 diabetes. It works by mimicking natural hormones in your body to lower blood sugar levels. People often ask, 'What is Ozempic used for?' This medication is designed to improve glycemic control as part of a comprehensive diabetes management plan.

Side Effects

Common effects of Ozempic .68 mg/mL may include nausea, diarrhea, and constipation. Some users also experience decreased appetite. These effects can vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Handle Ozempic .68 mg/mL with care, storing it as directed to maintain its efficacy. This medication should be used under medical supervision. Avoid sharing needles and follow proper disposal guidelines for used syringes.

Avoid Interactions

Ozempic .68 mg/mL may interact with other medications, including those that affect blood sugar levels. It's important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.

Frequently Asked Questions

Ozempic .68 mg/mL is used for managing type 2 diabetes by helping to control blood sugar levels.

Ozempic .68 mg/mL is administered via subcutaneous injection, typically in the abdomen, thigh, or upper arm.

Common side effects may include nausea, diarrhea, constipation, and decreased appetite.

Ozempic .68 mg/mL may interact with other diabetes medications, so it's important to consult a healthcare provider before combining treatments.

Ozempic .68 mg/mL should be stored in the refrigerator between 36°F to 46°F (2°C to 8°C) and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.